Clinical Trials for Aplagon

Explore 1 clinical trials worldwide

Showing 1-1 of 1 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: Aplagon

Clinical Trials (1)

NCT06204237
Safety, Tolerability, and Biodistribution of [89Zr]Zr-DFO-APAC in Subjects With PAOD/CLI and Healthy Volunteers (Acronyms: 89Zr = Zirconium-89, DFO = Desferrioxamine, APAC = AntiPlatelet AntiCoagulant, PET/CT = Positron Emission Tomography/Computed Tomography)
EARLY_PHASE1Recruiting
10 participants
Started: Feb 1, 2024 · Completed: Jun 30, 2025
2 conditions2 sponsors1 location